Stada CEO discovers he’s under surveillance as deal action heats up esagonowsky Mon, 03/27/2017 – 11:15 More: Stada CEO discovers he's under surveillance as deal action heats up Source: fierce
read moreSix new medicines, including three orphan drugs for rare diseases, have been backed for European Union approval by the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP). More: Six new medicines backed for EU approval Source: News
read moreMSD’s anti-PD-1 therapy Keytruda has taken a giant leap towards being approved in Europe for the treatment of classical Hodgkin Lymphoma (cHL). More: MSD’s Keytruda closer to classical Hodgkin Lymphoma nod Source: News
read moreSome patients with moderate to severe forms of rheumatoid arthritis could get access to a new treatment option in Europe following the approval of Pfizer’s oral Janus kinase (JAK) inhibitor Xeljanz. More: Pfizer bags approval for RA drug Xeljanz Source:
read moreDaiichi Sankyo More: U.S. FDA grants fast track designation for her2-targeting antibody drug conjugate DS-8201 for HER2-positive metastatic breast cancer Source: MDlinx
read moreMerck More: European medicines agencys CHMP recommends approval of Merck's KEYTRUDA® (Pembrolizumab) for the treatment of patients with relapsed or refractory classical Hodgkin lymphoma Source: MDlinx
read more© 1994 - 2024 B.M. Pharmaceuticals